science

Pembrolizumab/berahyaluronidase alfa

Pembrolizumab/berahyaluronidase alfa is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pembrolizumab/berahyaluronidase alfa rather than just read about it. In short: Pembrolizumab/berahyaluronidase alfa, sold under the brand name Keytruda Qlex, is a fixed dose combination medication used for the treatment of many types of solid tumors. It contains pembrolizumab, a programmed death receptor-1 (PD-1) blocking antibody; and berahyaluronidase alfa, a variant of hyaluronidase.

Key takeaways

Pembrolizumab/berahyaluronidase alfa belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Pembrolizumab/berahyaluronidase alfa to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Pembrolizumab/berahyaluronidase alfa from memory before moving on to harder problems.

Reference excerpt

Pembrolizumab/berahyaluronidase alfa, sold under the brand name Keytruda Qlex, is a fixed dose combination medication used for the treatment of many types of solid tumors. It contains pembrolizumab, a programmed death receptor-1 (PD-1) blocking antibody; and berahyaluronidase alfa, a variant of hyaluronidase. It is given by injection under the skin (subcutaneous). Pembrolizumab/berahyaluronidase alfa was approved for medical use in the United States in September 2025.

Medical uses Pembrolizumab/berahyaluronidase alfa is indicated for the solid tumor indications approved for the intravenous formulation of pembrolizumab.

Side effects The US FDA prescribing information includes warnings and precautions for immune-mediated adverse reactions, hypersensitivity and administration-related reactions, complications of allogeneic hematopoietic stem cell transplantation, and embryo-fetal toxicity.

History The efficacy was evaluated in study MK-3475A-D77 (NCT05722015), a randomized, multi-center, open-label, active-controlled trial conducted in participants with treatment-naïve metastatic non-small cell lung cancer, in whom there were no EGFR, ALK, or ROS1 genomic tumor aberrations. A total of 377 participants were randomized (2:1) to receive either pembrolizumab/berahyaluronidase alfa administered subcutaneously every six weeks with platinum doublet chemotherapy or pembrolizumab administered intravenously every six weeks with platinum doublet chemotherapy.

Society and culture

Legal status Pembrolizumab/berahyaluronidase alfa was approved for medical use in the United States in September 2025.

Names Pembrolizumab and berahyaluronidase alfa are international nonproprietary names. Pembrolizumab/berahyaluronidase alfa is sold under the brand name Keytruda Qlex.

References

External links Clinical trial number NCT05722015 for "A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)" at ClinicalTrials.gov

Worked examples

Example 1 — a first encounter with Pembrolizumab/berahyaluronidase alfa

Start with the simplest possible case. Write down what Pembrolizumab/berahyaluronidase alfa claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pembrolizumab/berahyaluronidase alfa before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pembrolizumab/berahyaluronidase alfa ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pembrolizumab/berahyaluronidase alfa

In research: Pembrolizumab/berahyaluronidase alfa appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Pembrolizumab/berahyaluronidase alfa in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Pembrolizumab/berahyaluronidase alfa is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antineoplastic drugs, Cancer immunotherapy, Drugs developed by Merck & Co., so understanding it makes those chapters shorter.
In everyday life: Look for Pembrolizumab/berahyaluronidase alfa outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Pembrolizumab/berahyaluronidase alfa” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pembrolizumab/berahyaluronidase alfa in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Pembrolizumab/berahyaluronidase alfa means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Pembrolizumab/berahyaluronidase alfa out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pembrolizumab/berahyaluronidase alfa in simple terms?

Why does Pembrolizumab/berahyaluronidase alfa matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pembrolizumab/berahyaluronidase alfa?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pembrolizumab/berahyaluronidase alfa.